Substantiating EBV’s causal role in MS has been fraught with challenges, partly because EBV infections are so common. About 95% of adults get infected with the virus, yet only a tiny fraction of people ever develops MS. Moreover, the onset of MS symptoms occurs, on average, a decade after EBV infection, and some studies have found that MS develops 30 years after the EBV caused mononucleosis, says Kassandra Munger, Sc.D., a senior research scientist at Harvard public health school and one of the study’s two senior co-authors. “We can consider EBV necessary to developing MS, but there need to be other mitigating factors, such as a genetic predisposition,” says Munger says. Cigarette smoking, vitamin D deficiency and obesity, particularly early in life, could play a role in whether EBV infection leads to MS. https://www.managedhealthcareexecutive.com/view/harvard-researchers-identify-epstein-barr-virus-as-a-cause-of-ms